Proteomedix Company

Identification of novel biomarkers for the early detection of cancer

Funding Status: N/A
Headquarters: Schlieren, Zurich
Founded Date: 2010
Investor Type: N/A
Investment Stage: N/A
Total Funding: $21.3M
Technology: ELISA
Employee Number: 1-10
Number Of Exists: N/A
Estimated Revenue: $1M to $10M
Industry: BioTech